Current prescribing patterns for hypertension and atherosclerotic cardiovascular disease (ASCVD) in MSF programmes and their association with treatment outcomes and renal function: could there be a role for fixed dose combination drugs?
Principal investigator
-
Methodology
-
ReferenceOCA018-66
Purpose of study
Purpose of study
The purpose of the study is to inform the revision of guidelines for hypertension and ASCVD care in MSF noncommmunicble (NCD) disease projects, to simplify treatment for both patient and prescriber, in order to improve overall medication use (pres...
-
Concept
-
Protocol & ERB
-
Implementation
-
Completion
-
Archived
Study timeline
-
Publication added by Holly Baker
4th June 2022 -
Publication added by Holly Baker
12th April 2022 -
Publication added by Holly Baker
19th August 2020 -
Concept paper added
22nd October 20192018_CN_Retropsective_Hypertension_AR.docx35.4 KB
Documents
Publications
-
Implementation of fixed-dose combination therapy for secondary prevention of atherosclerotic cardiovascular disease among Syrian refugees in Lebanon: a qualitative evaluationMurphy, Adrianna "–" Springer Science and Business Media LLC "(2022)"
-
Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular DiseasesWebster, Ruth "–" Ubiquity Press, Ltd. "(2020)"
-
Addressing Failures in Achieving Hypertension Control in Low- and Middle-Income Settings through Simplified Treatment AlgorithmsCohn, Jennifer "–" Ubiquity Press, Ltd. "(2022)"
Previous study
Next study